Category: Drug Testing
Oxycodones positivity declines for the second consecutive year
The latest data from the Quest Diagnostics Drug Testing Index reports that the positivity rate for prescription opiates declined 8.3% in 2013.
Avoid common substance abuse program mistakes
Mark A. de Bernardo discusses tips to create an effective workplace policy and substance abuse prevention program in our recent webinar.
Webinar insights: Tracking the trends
Dr. Barry Sample, Director of Science and Technology, reviewed key data and insights from the Quest Diagnostics Drug Testing Index.
Webinar: Tracking the trends
Industry expert Dr. Barry Sample discusses the latest data from the Quest Diagnostics Drug Testing Index.
Webinar: 12 common (and costly) employer mistakes
Mark A. de Bernardo discusses how employers can avoid common pitfalls and maximize the effectiveness of substance-abuse prevention programs.
International drug testing questions & answers
Coleen Volksdorf, Manager of International Services, at Quest Diagnostics, was recently featured in the IFDAT Global Insider.
Ask the experts: Under the influence
Is oral fluid is the best drug test specimen type for determining whether an employee is under the influence of drugs – particularly marijuana?
Ask the experts: Urine – the ‘gold standard’ of drug testing
Businesses who take part in drug-free workplace programs need flexible testing methods and lab-based urine drug testing offers robust panels.
Drug testing collection site network
Not all collection sites are created equal, and it’s important to know the differences between each type of site when making a location selection.
Revised urine specimen collector guidelines
ODAPC issued an official Q&A document that clarifies collector guidelines outlined in 49 CFR Part 40.
